comparemela.com
  1. Home
  2. Live Updates
  3. NeuroBo Pharmaceuticals (NRBO) Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity : comparemela.com

NeuroBo Pharmaceuticals (NRBO) Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

NeuroBo Pharmaceuticals (NRBO) Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726 for the Treatment of Obesity

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

,Drug Administration ,Nasdaq ,Neurobo Pharmaceuticals Inc ,Neurobo Pharmaceuticals ,Investigational New Drug ,Icheon Kim ,Chief Executive Officer ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.